This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Healthy
and you are
between 20 and 40
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to examine the pharmacokinetic properties of Tapimycin injection (piperacillin 4 g + tazobactam 0.5 g powder for injection) in healthy volunteers under fasting conditions.

Provided treatments

  • Drug: Tapimycin (piperacillin 4 g + tazobactam 0.5g)
Tris trial is registered with FDA with number: NCT00924742. The sponsor of the trial is Tri-Service General Hospital and it is looking for 12 volunteers for the current phase.
Official trial title:
A Single-Dose Pharmacokinetics Study of Tapimycin Injection(Piperacillin 4 g + Tazobactam 0.5 g Powder for Injection) Administered Under Fasting Conditions to Healthy Adult Subjects